Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.41 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL1478373 | 0.98 | OPRK1 (0.41) | OPRK1ALDH1A1TSHRHPGDCHRM2 | |
| SCHEMBL5738047 | 0.98 | OPRK1 (0.41) | OPRK1ALDH1A1TSHRHPGDCHRM2 | |
| SCHEMBL2011475 | 0.90 | HPGD (0.39) | OPRK1ALDH1A1TSHRHPGDEPHX2 | |
| SCHEMBL15659951 | 0.85 | ALDH1A1 (0.42) | OPRK1ALDH1A1TSHRHPGDCHRM2 | |
| SCHEMBL2015640 | 0.84 | ALDH1A1 (0.39) | OPRK1ALDH1A1TSHRHPGDP2RX7 | |
| SCHEMBL1734830 | 0.82 | P2RX7 (0.39) | OPRK1ALDH1A1TSHRHPGDEPHX2 | |
| SCHEMBL6465665 | 0.82 | EPHX2 (0.33) | OPRK1ALDH1A1TSHRHPGDEPHX2 | |
| SCHEMBL21562234 | 0.82 | HSD11B1 (0.37) | OPRK1ALDH1A1TSHRHPGDCHRM2 | |
| SCHEMBL2830096 | 0.81 | P2RX7 (0.38) | OPRK1ALDH1A1TSHRHPGDEPHX2 | |
| SCHEMBL16573840 | 0.80 | EPHX2 (0.38) | OPRK1ALDH1A1TSHRHPGDCHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2427468-B2 | PREPARATION OF A METAL COMPLEX | JOHNSON MATTHEY PLC (GB) | 2025-06-04 | — | — | EP | claimed |
| CN-118420533-A | Method for synthesizing isoquinolinone by carbonylation of aryl alkyne and hydroxylamine | 中国科学技术大学 | 2024-08-02 | — | — | CN | claimed |
| EP-4267591-A2 | ORGANOMETALLIC COMPOUNDS | Umicore AG & Co. KG (DE) | 2023-11-01 | — | — | EP | claimed |
| CN-116802187-A | Organometallic compounds | 优米科尔股份公司及两合公司 | 2023-09-22 | — | — | CN | claimed |
| CN-116655587-A | Preparation method of suprofen | 酒泉职业技术学院(甘肃广播电视大学酒泉市分校) | 2023-08-29 | — | — | CN | claimed |
| CN-116082157-A | Method for preparing organic carboxylic ester by olefine unsaturated compound alkoxycarbonyl reaction | 上海梓龄化工技术有限公司 | 2023-05-09 | — | — | CN | claimed |
| WO-2022136049-A2 | ORGANOMETALLIC COMPOUNDS | UMICORE AG & CO. KG (DE) | 2022-06-30 | — | — | WO | claimed |
| EP-3369723-B1 | METHOD FOR MANUFACTURING ARYL AND HETEROARYL ACETIC ACID DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2020-10-14 | — | — | EP | claimed |
| CN-106928061-B | Continuous process for the carbonylation of ethylene | 璐彩特国际英国有限公司 | 2020-08-28 | — | — | CN | claimed |
| EP-3369723-A1 | METHOD FOR MANUFACTURING ARYL AND HETEROARYL ACETIC ACID DERIVATIVES | Bayer CropScience Aktiengesellschaft (DE) | 2018-09-05 | — | — | EP | claimed |
| WO-2010128316-A1 | PREPARATION OF A METAL COMPLEX | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2010-11-11 | — | — | WO | claimed |
| EP-1303525-B1 | PRODUCTION OF NOVEL PHOSPHANE LIGANDS AND USE IN CATALYTICAL REACTIONS | EVONIK DEGUSSA GMBH (DE) | 2010-09-08 | — | — | EP | claimed |
| US-20100022780-A1 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-01-28 | — | — | US | claimed |
| EP-2102150-A1 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-09-23 | — | — | EP | claimed |
| WO-2008070158-A1 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-06-12 | — | — | WO | claimed |
| EP-1748976-A1 | ALKOXYCARBONYLATION OF VINYL ESTERS | Lucite International UK Limited (GB) | 2007-02-07 | — | — | EP | claimed |
| WO-2005118519-A1 | ALKOXYCARBONYLATION OF VYNIL ESTERS | LUCITE INTERNATIONAL UK LTD (GB) | 2005-12-15 | — | — | WO | claimed |
| JP-2005535695-A | — | — | 2005-11-24 | — | — | JP | claimed |
| EP-1527038-A1 | PROCESS FOR THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUDS | Lucite International UK Limited (GB) | 2005-05-04 | — | — | EP | claimed |
| WO-2004014834-A1 | PROCESS FOR THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUDS | LUCITE INTERNATIONAL UK LIMITED (GB) | 2004-02-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022780-A1 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES | PRMT6, C5, CHRM1 | OPRK1 2221/4885ALDH1A1 756/4885TSHR 1137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.